Related Experiment Video

Updated: May 29, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

[Genetic susceptibility to retinopathy of prematurity]

Jia-kai Li1, Pei-quan Zhao

  • 1Xinhua College of Clinical Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.

[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|September 15, 2011
PubMed

Insights

Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Emerging evidence suggests genetic factors, including ethnicity and gene variations, play a significant role in ROP development and may guide future treatments.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Genetics

Context:

  • Retinopathy of prematurity (ROP) is a significant cause of pediatric blindness globally.
  • Despite advances, the exact causes and mechanisms of ROP remain incompletely understood.
  • Premature birth, low birth weight, and short gestational age are established risk factors.

Purpose:

  • To review the current understanding of retinopathy of prematurity (ROP).
  • To explore the role of genetic factors in ROP development.
  • To discuss the implications of genetic susceptibility for future ROP management.

Summary:

  • ROP is a serious eye condition affecting premature infants, leading to potential blindness.
  • While prematurity is a primary risk, genetic factors like sex, ethnicity, gene polymorphisms, and mutations are increasingly recognized.
  • These genetic predispositions influence individual susceptibility to ROP.

Impact:

  • Understanding ROP's genetic basis can refine screening protocols for high-risk infants.
  • Genetic insights may pave the way for targeted therapies for advanced ROP.
  • This knowledge is crucial for reducing the global burden of childhood blindness caused by ROP.

More Related Videos

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genetic Lingo01:11

Genetic Lingo

Overview